IL6 and lymphoma: Also, since stromal elements were supporting DS-1 cell proliferation, these could also have been targeted by IL-6 trans-signaling inhibitor, leading to diminished local IL-6 secretion and overall impairment of stromal and lymphoma cell proliferation.